D. J. M. Peters

Learn More
INTRODUCTION AND AIMS The DIPAK-1 Study investigates the reno- and hepatoprotective efficacy of the somatostatin analog lanreotide compared with standard care in patients with later stage autosomal(More)
BACKGROUND The renoprotective effect of vasopressin V2 receptor antagonist (V2RA) is currently being tested in a clinical trial in early autosomal dominant polycystic kidney disease (ADPKD). If(More)
The CLN3 gene is involved in juvenile neuronal ceroid lipofuscinosis (JNCL), or Batten–Spielmeyer–Vogt disease, a severe hereditary neurodegenerative lysosomal storage disorder characterized by(More)